Ayahuasca: Effects, Risks, Interactions and Legal Status
Ayahuasca is a psychoactive Amazonian brew combining DMT with MAO-inhibiting harmala alkaloids, used ceremonially for generations. This educational reference covers its pharmacology, physical and psychological risks, dangerous interactions with SSRIs and other serotonergic drugs, addiction questions, harm-reduction principles, and legal status. It is not medical advice; consult professionals.
What Ayahuasca Is
Ayahuasca is a psychoactive brew from the Amazon basin, traditionally made by combining the Banisteriopsis caapi vine with a DMT-containing plant such as Psychotria viridis (chacruna). Its effects come from two parts working together. DMT is the main visionary compound, and it is normally broken down in the gut by an enzyme called monoamine oxidase. The caapi vine supplies harmala alkaloids (harmine, harmaline, tetrahydroharmine) that reversibly inhibit monoamine oxidase, which allows orally consumed DMT to become active. This reference concerns adults and is for education and harm reduction only.
The harmala alkaloids, sometimes called beta-carbolines, act mainly on MAO-A and are reversible inhibitors, which distinguishes them from older irreversible MAOI antidepressants. Without an MAO inhibitor, oral DMT has little to no effect. Preparations vary widely in strength and plant composition depending on region, tradition, and preparer, so no two brews are identical. Recipes and admixture plants differ across the Amazon.
History and Traditional or Spiritual Use
Ayahuasca has a long history among Indigenous peoples of the western Amazon, in what is now Peru, Colombia, Ecuador, Brazil, and neighboring regions, where it is used in healing, divination, and community ritual guided by experienced practitioners. Mestizo folk healing traditions known as vegetalismo grew from this Indigenous knowledge. In the twentieth century, several Brazilian syncretic churches, including Santo Daime, the Uniao do Vegetal (UDV), and Barquinha, incorporated the brew into organized religious practice that blends Christian, Indigenous, and Afro-Brazilian elements.
In these settings ayahuasca is treated as a sacred medicine used within structured ceremony, songs (icaros), dietary practices, and the guidance of a healer or church. Since the late twentieth century, retreat and tourism industries have grown around ayahuasca in South America and elsewhere, which raises safety, ethical, and cultural questions the traditional context did not face, including the presence of untrained or unscrupulous facilitators.
General Effects
Ayahuasca typically produces altered perception, vivid visual imagery, shifts in mood and thought, and a strong sense of emotional or introspective significance. Onset usually follows within roughly an hour of drinking, and the experience commonly lasts several hours before subsiding. Physical effects frequently include nausea, vomiting, and diarrhea, which many traditions regard as part of the process and call la purga, meaning the purge. Experiences vary enormously between people and between sessions and can range from calm to intensely difficult.
Reported effects also include changes in heart rate and blood pressure, sweating, tremor, and dilated pupils. The psychological experience is highly sensitive to expectation, emotional state, and environment. Difficult or frightening passages are common and are sometimes described as challenging experiences rather than adverse ones, though the line depends on the person and the support available. No numbers, doses, or measurements are given here by design.
Risks and Dangers
Ayahuasca carries real physical and psychological risks. Physically it raises heart rate and blood pressure and can cause vomiting and dehydration, which is more concerning for people with cardiovascular disease or other medical conditions. Psychologically it can provoke intense fear, confusion, and lasting distress. It may trigger or worsen psychosis or mania in people with a personal or family history of schizophrenia, bipolar disorder, or related conditions. Serious adverse events, including seizures and rare deaths, have been reported, often involving pre-existing conditions, unscreened participants, or dangerous drug combinations.
Safety in pregnancy and breastfeeding has not been established, so it is treated as contraindicated. Risk rises sharply in unregulated retreat settings where medical screening is absent, where facilitators are untrained, and where participants may be taking undisclosed medications. Psychological vulnerability, isolation, and lack of aftercare can turn a difficult experience into a prolonged crisis. Anyone experiencing a medical or psychiatric emergency should seek professional emergency help immediately.
Dangerous Interactions and Contraindications
Because ayahuasca contains a monoamine oxidase inhibitor, it interacts dangerously with a wide range of drugs and some foods. Combining ayahuasca or DMT with SSRIs, SNRIs, other MAOIs, or other serotonergic drugs can cause serotonin syndrome, a potentially life-threatening reaction whose signs include agitation, confusion, high fever, rapid heart rate, muscle rigidity, tremor, and seizures. This is a medical emergency requiring immediate care. MAO inhibition also creates risks with tyramine-rich aged foods and with many stimulants, opioids such as tramadol, and cough medicines containing dextromethorphan.
St. John's Wort and other serotonergic supplements add to the same risk. People do not always tell facilitators or physicians about medications or supplements, which is a major source of severe interactions. Kratom is a separate substance sometimes discussed in the same spaces; it carries its own dependence potential and can interact dangerously with other drugs, and mixing serotonergic or opioid substances compounds risk. Contraindications commonly cited include serious cardiovascular disease, uncontrolled high blood pressure, a personal or family history of psychosis or bipolar disorder, pregnancy, and use of any interacting medication. Medication changes must only be made under a prescriber's supervision, since stopping antidepressants abruptly is itself hazardous.
Harm-Reduction Principles
Harm reduction accepts that some adults will make their own choices and focuses on reducing preventable harm. Core principles include honest medical and psychiatric screening for contraindications, a full and truthful review of all medications and supplements with a qualified professional, and never mixing ayahuasca with alcohol, sedatives, or other central nervous system depressants or serotonergic drugs. Set and setting matter: a stable mindset, a safe environment, and trustworthy sober support reduce the chance of a crisis. Planning for integration afterward helps people process difficult material.
Additional principles include verifying what is actually in a preparation rather than assuming, since composition and strength are unpredictable and adulteration is possible; substance testing has real limits with plant brews and does not make an experience safe. Sober, experienced support and access to help are important because a person under the influence cannot reliably care for themselves. Integration means working through the experience afterward, sometimes with a therapist trained in this area. None of these steps make ayahuasca safe, and they do not remove the legal and medical risks. This is general information, not medical or legal advice.
Addiction and Dependence Potential
Classic serotonergic psychedelics, including the DMT in ayahuasca, are generally considered to have low potential for compulsive use and physical dependence, and rapid tolerance tends to discourage frequent repeated dosing. Some observational and clinical work in the Amazon has even explored ayahuasca within addiction treatment programs. Low physical dependence does not mean the experience is harmless. Psychological reliance, avoidance of ordinary life, and repeated use in poorly supervised settings can still cause harm, and any interacting medications or health conditions remain dangerous regardless of dependence potential.
The addiction-treatment research is preliminary and comes largely from specific supervised or ceremonial contexts, so it should not be read as evidence that ayahuasca is a proven treatment or that self-directed use is safe. Claims that it cures addiction or other conditions go beyond what current evidence supports. Kratom, by contrast, does carry meaningful dependence and withdrawal potential and should not be treated as equivalent.
Legal Status
Legal status varies by country, and in most places the DMT in ayahuasca is a controlled substance. In the United States, DMT is Schedule I under the Controlled Substances Act, which makes ayahuasca illegal to import, possess, sell, or distribute, with narrow religious exemptions granted to specific churches such as the UDV and Santo Daime through the Religious Freedom Restoration Act. Some countries, including Peru and Brazil, permit traditional or religious use under defined conditions, while many others prohibit it outright.
Because DMT is scheduled under international drug conventions, the underlying compound is controlled in most jurisdictions even where a specific brew is not named in statute. Enforcement, court rulings, and religious exemptions continue to evolve, and traveling with or importing ayahuasca can carry serious legal consequences. Anyone weighing the law should consult current, jurisdiction-specific legal sources rather than relying on general summaries. This section is educational and is not legal advice.
Frequently Asked Questions
Can you take ayahuasca while on antidepressants?
Combining ayahuasca with SSRIs, SNRIs, MAOIs, or other serotonergic medications is dangerous and can cause serotonin syndrome, a potentially life-threatening reaction. The harmala alkaloids in ayahuasca inhibit monoamine oxidase, which compounds the risk. Never stop or change psychiatric medication on your own, since abrupt discontinuation is also hazardous. Any decision must involve the prescribing professional. This is a common and serious source of harm.
Is ayahuasca addictive?
The DMT in ayahuasca is generally considered to have low potential for physical dependence, and rapid tolerance tends to discourage frequent use. That does not make it safe. Psychological reliance and repeated use in poorly supervised settings can still cause harm, and dangerous drug interactions and health contraindications remain regardless of dependence potential. Kratom, a separate substance, does carry real dependence and withdrawal risk.
Is ayahuasca legal?
In most countries the DMT in ayahuasca is a controlled substance. In the United States it is Schedule I and illegal to possess, import, or distribute, with narrow religious exemptions for specific churches such as the UDV and Santo Daime. Some countries like Peru and Brazil allow traditional or religious use under conditions. Laws change and vary; consult current jurisdiction-specific legal sources.
What are the main risks of ayahuasca?
Risks include raised heart rate and blood pressure, vomiting and dehydration, intense fear or confusion, and lasting psychological distress. It can trigger or worsen psychosis or mania in vulnerable people. The most serious dangers involve combining it with interacting medications, unscreened medical conditions, and untrained facilitators. Serious adverse events, including seizures and rare deaths, have been reported. Seek emergency help for any medical or psychiatric crisis.
Who should not use ayahuasca?
Commonly cited contraindications include serious cardiovascular disease or uncontrolled high blood pressure, a personal or family history of schizophrenia, bipolar disorder, or psychosis, pregnancy and breastfeeding, and use of any interacting medication or supplement such as SSRIs, MAOIs, tramadol, dextromethorphan, or St. John's Wort. This concerns adults only. Anyone considering it should first consult qualified medical and mental health professionals.
Try Our Free Tools
Related topics: ayahuasca, DMT, harmala alkaloids MAOI, serotonin syndrome SSRI interaction, ayahuasca risks and harm reduction, ayahuasca legal status, Banisteriopsis caapi, plant medicine safety
